Poria Dorali

Poria Dorali

Auto-generated profile, based on publicly available information

Poria Dorali

Department of Public Health Sciences, Medical University of South Carolina , Charleston, SC

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2023 in Ophthalmology Retina
Verified
Journal Article
Closed access
PDPoria Dorali
Poria Dorali
ZSZahed Shahmoradi
Zahed Shahmoradi
CWChristina Y. Weng
Christina Y. Weng
TLTaewoo Lee
Taewoo Lee

9 January 2026 in JNCI Cancer Spectrum
Verified
Journal Article
Open access
TATrisha Amboree
Trisha Amboree
PDPoria Dorali
Poria Dorali
HDHaluk Damgacioglu
Haluk Damgacioglu
JMJane R Montealegre
Jane R Montealegre
MFMarvella Elizabeth Ford
Marvella Elizabeth Ford
ADAshish A Deshmukh
Ashish A Deshmukh
Cervical cancer elimination (<4 cases per 100 000) is a critical cancer prevention goal in the United States. Implementation of health policies and allocation of health resources occur at regional and state levels; therefore, understanding region- and state-specific cervical cancer incidence, mortality, and progress toward elimination—and remaining gaps—is essential. We estimated hysterectomy-corrected cervical cancer incidence, mortality, and progress toward elimination across all 50 states, the District of Columbia, and Puerto Rico. In 2021, Massachusetts was the only state nearing (4.3 per 100 000) the elimination threshold. Southeastern and Southwestern states were furthest, with the highest incidence rates in Mississippi (14.8), Louisiana (14.2), and Oklahoma (13.8). The mortality rate ranged from 6.8 (Alabama) to 1.4 (Wisconsin). In most states, cervical cancer incidence and mortality did not change from 2007-2011 to 2017-2021. Identifying and addressing regional- and state-level barriers impeding progress will be key to achieving cervical cancer elimination.

1 September 2025 in JNCI Cancer Spectrum
Verified
Journal Article
Open access
PDPoria Dorali
Poria Dorali
HDHaluk Damgacioglu
Haluk Damgacioglu
TATrisha Amboree
Trisha Amboree
AOAna Patricia Ortiz
Ana Patricia Ortiz
BOBrian C Orr
Brian C Orr
ADAshish A Deshmukh
Ashish A Deshmukh
Socioeconomically disadvantaged counties exhibit higher cervical cancer incidence and poorer survival. However, the specific impact of the magnitude of persistent poverty on these outcomes remains largely unexamined. Using national cancer registry data, we observed that women living in persistent poverty counties who have experienced extreme poverty (≥40% poverty) have more than 1.5 times higher cervical cancer incidence and twice the mortality rate as women who lived in nonpersistent poverty counties. Furthermore, stage-specific incidence was consistently higher in persistent poverty counties across localized, regional, and distant diagnoses. Five-year mortality for localized cervical cancer diagnoses was nearly twice as high in extreme poverty counties (11% vs 6%, 2-sided P = .03). These findings highlight substantial disparities in cervical cancer outcomes associated with increasing magnitude of persistent poverty and underscore the need for targeted interventions in economically vulnerable communities to reduce disparities and achieve cervical cancer elimination goals.